Our objective was to assess non‐inferiority of the unique approach used in our institution of combined 10 IU IM (intramyometrial) and 10 IU IV (intravenous) oxytocin to carbetocin IV in preventing severe… Click to show full abstract
Our objective was to assess non‐inferiority of the unique approach used in our institution of combined 10 IU IM (intramyometrial) and 10 IU IV (intravenous) oxytocin to carbetocin IV in preventing severe postpartum blood loss in elective cesarean sections. The design was a prospective controlled phase IV non‐inferiority interventional trial. The setting was a tertiary center at University Hospital, Zurich, Switzerland.
Keywords:
controlled phase;
intramyometrial intravenous;
elective cesarean;
non inferiority;
intravenous oxytocin;
inferiority
Journal Title: Acta Obstetricia et Gynecologica Scandinavica
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Obstetricia et Gynecologica Scandinavica
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!